Merck KGaA (OTCMKTS:MKGAF) Shares Gap Up – Here’s Why

Merck KGaA (OTCMKTS:MKGAF)’s share price gapped up prior to trading on Thursday. The stock had previously closed at $149.9670, but opened at $158.3510. Merck KGaA shares last traded at $158.3510, with a volume of 10 shares traded.

Merck KGaA Stock Up 2.8%

The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The company has a 50-day simple moving average of $160.88 and a two-hundred day simple moving average of $150.15. The stock has a market cap of $20.61 billion, a P/E ratio of 24.34 and a beta of 0.96.

Institutional Investors Weigh In On Merck KGaA

Several institutional investors have recently added to or reduced their stakes in MKGAF. MASTERINVEST Kapitalanlage GmbH bought a new stake in Merck KGaA in the 2nd quarter worth $4,896,000. Puzo Michael J bought a new position in shares of Merck KGaA during the second quarter valued at about $2,230,000. Somerville Kurt F bought a new position in shares of Merck KGaA during the second quarter valued at about $1,997,000. Pinnacle Holdings LLC purchased a new stake in shares of Merck KGaA during the second quarter worth about $1,487,000. Finally, North Star Asset Management Inc. purchased a new stake in shares of Merck KGaA during the second quarter worth about $1,411,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.

Merck KGaA Company Profile

Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest operating pharmaceutical and chemical companies. The business serves customers in more than 60 countries through three operating sectors: Healthcare, Life Science and Electronics.

The Healthcare sector develops and markets prescription medicines and specialty therapies, with activities focused on areas including oncology, neurology and immunology, fertility, and endocrinology.